Hubert L. Allen, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 584 shares at $46.38 ($27K) on 2015-02-17, disclosed to the SEC on 2015-02-19.
Scheduled sale ($27k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.09 | 412 | $19K | 70.4% |
| 2 | $46.38 | 172 | $8K | 29.6% |
| Total | $46.18 avg | 584 | $27K | 100% |
| Filing → |
| ABT | SELL | 2024-03-04 | $202K | — | Filing → |
| ABT | SELL | 2023-03-02 | $215K | — | Filing → |
| ABT | SELL | 2022-03-02 | $343K | — | Filing → |